Clinical Nutrition Market Overview
The global clinical nutrition market size was valued at $32,495.97 million in 2020, and is projected to reach $51,128.26 million by 2028, registering a CAGR of 6.1% from 2021 to 2028.
Clinical nutrition is a type of pharmaceutical product to keep the patient healthy by providing required amount of nutrients such as proteins, vitamins, and minerals. These nutrition aids in the improvement of the functions of metabolic, discharge, and absorption of the body. This nutrition provides essential nutrients such as minerals, proteins, and vitamins. Further, nutrition science is an amalgamation of science and healthcare, which offers a broad field of nutritional medicines. Clinical nutrition is used in treatment of the diseases that are related to the clinical nutrition malnutrition & therapies. Further, nutrition advancements are also helping people to get a proper diet and balance functioning of the body. The clinical nutrition works in acute and ambulatory care settings such as cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, and wellness centers-based intervention programs. Further, the clinical malnutrition is a disease which is treated only with clinical intervention, by the help of the specialized nutrients that are considered as proper medications, rather than as supplements. In addition, the key players are also aiming on expansion through various strategies, such as acquisition, merger, strategic collaboration, and others, to achieve substantial market share and strengthen their product portfolios. Thus, this is expected to provide a lucrative opportunity during the forecast period.
The growth of the clinical nutrition market is driven by increase in prevalence of chronic disorders and rise in number of patients using advanced clinical nutritional product. In addition, rise in R&D investments by the government in healthcare are some of the major factors that boost the global clinical nutrition market. However, lack of awareness and stringent regulations hampers the growth of the clinical nutrition market. On the contrary, rise in advancements in clinical nutrition and rise in various growth opportunities for clinical nutrition products in an emerging countries are expected to offer lucrative opportunities for the global clinical nutrition market players.
The global clinical nutrition market is segmented based on route of administration, application, end user, and region. On the basis of route of administration, the market is divided into oral, enteral, and parenteral. Depending on application, it is classified into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. By end user, the market is segregated into pediatric, adults, and geriatric. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Route of Administration segment review
Based on route of administration, the market is categorized into oral, enteral, and parenteral. The oral segment accounted for the largest share in 2018 and is expected to continue the trend throughout the forecast period. This growth is attributed to its wide usage in patients owing to its easy intake and availability for several diseases.
Application segment review
Depending on application, the market is categorized into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. The cancer is projected to be the fastest growing segment during the forecast period. This is attributed to the nutritional deficiency that arises in patients due to various cancer treatments such as chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplant.
End User segment review
Based on end user, the market is categorized into pediatric, adult, and geriatric. The pediatric segment accounted for the largest share in 2018, and will continue the trend during the forecast period. Rising concern of malnutrition in pediatric patients across the globe is expected to be the major driver for the growth of the clinical nutrition market for pediatric segment.
Region segment review
Region wise, the clinical nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the leading revenue contributor to the global clinical nutrition market in 2018, and is anticipated to dominate the market during the forecast period, due to upsurge in number of chronic disease such as coronary artery disease, ischemic stroke, diabetes, and few cancer indications, and increase in geriatric population. In addition, initiative taken by the U.S. government to promote the complete nutrition care for the cancer patients is anticipated to drive the market further. However, Asia-Pacific is expected to experience the fastest CAGR during the forecast period, due to increase in metabolic disorders, high disposable incomes, and improvement in patient awareness regarding the adoption of clinical nutrition products.
The report provides a comprehensive analysis of the key players operating in the global clinical nutrition market, which include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Nestlé S.A, Lonza Ltd., and Hero Nutritionals Inc. The other players in the value chain (companies not included in the report) include Ajinomoto Co. Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, and H. J. Heinz Company.
Key Benefits For Stakeholders
Key Market Segments
By Route Of Administration
By Application
By End User
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in incidence of chronic diseases and lifestyle associated disease
3.3.1.2.Surge in geriatric population across the globe
3.3.2.Restraint
3.3.2.1.Lack of awareness for clinical nutrition
3.3.3.Opportunity
3.3.3.1.Various growth opportunities in emerging economies
CHAPTER 4:CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION
4.1.Overview
4.1.1.Market size and forecast
4.2.Oral
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Enteral
4.3.1.Key trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Parenteral
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:CLINICAL NUTRITION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cancer
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Neurological Diseases
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Gastrointestinal Disorders
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Metabolic Disorders
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
CHAPTER 6:CLINICAL NUTRITION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Adults
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Geriatric
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:CLINICAL NUTRITION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key trends and opportunities
7.2.2.market size and forecast, by country
7.2.3.market size and forecast, by route of administration
7.2.4.Market size and forecast, by application
7.2.5.market size and forecast, by end user
7.2.6.U.S.
7.2.6.1.U.S. market size and forecast, by route of administration
7.2.6.2.U.S. market size and forecast, by application
7.2.6.3.U.S. market size and forecast, by end user
7.2.7.Canada
7.2.7.1.Canada market size and forecast, by route of administration
7.2.7.2.Canada market size and forecast, by application
7.2.7.3.Canada market size and forecast, by end user
7.2.8.Mexico
7.2.8.1.Mexico market size and forecast, by route of administration
7.2.8.2.Mexico market size and forecast, by application
7.2.8.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by route of administration
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.3.6.Germany
7.3.6.1.Germany market size and forecast, by route of administration
7.3.6.2.Germany market size and forecast, by application
7.3.6.3.Germany market size and forecast, by end user
7.3.7.UK
7.3.7.1.UK market size and forecast, by route of administration
7.3.7.2.UK market size and forecast, by application
7.3.7.3.UK market size and forecast, by end user
7.3.8.Spain
7.3.8.1.Spain market size and forecast, by route of administration
7.3.8.2.Spain market size and forecast, by application
7.3.8.3.Spain market size and forecast, by end user
7.3.9.France
7.3.9.1.France market size and forecast, by route of administration
7.3.9.2.France market size and forecast, by application
7.3.9.3.France market size and forecast, by end user
7.3.10.Italy
7.3.10.1.Italy market size and forecast, by route of administration
7.3.10.2.Italy market size and forecast, by application
7.3.10.3.Italy market size and forecast, by end user
7.3.11.Rest of Europe
7.3.11.1.Rest of Europe market size and forecast, by route of administration
7.3.11.2.Rest of Europe market size and forecast, by application
7.3.11.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by route of administration
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.6.Japan
7.4.6.1.Japan market size and forecast, by route of administration
7.4.6.2.Japan market size and forecast, by application
7.4.6.3.Japan market size and forecast, by end user
7.4.7.China
7.4.7.1.China market size and forecast, by route of administration
7.4.7.2.China market size and forecast, by application
7.4.7.3.China market size and forecast, by end user
7.4.8.India
7.4.8.1.India market size and forecast, by route of administration
7.4.8.2.India market size and forecast, by application
7.4.8.3.India market size and forecast, by end user
7.4.9.Australia
7.4.9.1.Australia market size and forecast, by route of administration
7.4.9.2.Australia market size and forecast, by application
7.4.9.3.Australia market size and forecast, by end user
7.4.10.Rest of Asia-Pacific
7.4.10.1.Rest of Asia-Pacific market size and forecast, by route of administration
7.4.10.2.Rest of Asia-Pacific market size and forecast, by application
7.4.10.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by route of administration
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
7.5.6.Brazil
7.5.6.1.Brazil market size and forecast, by route of administration
7.5.6.2.Brazil market size and forecast, by application
7.5.6.3.Brazil market size and forecast, by end user
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by route of administration
7.5.7.2.South Africa market size and forecast, by application
7.5.7.3.South Africa market size and forecast, by end user
7.5.8.Saudi Arabia
7.5.8.1.Saudi Arabia market size and forecast, by route of administration
7.5.8.2.Saudi Arabia market size and forecast, by application
7.5.8.3.Saudi Arabia market size and forecast, by end user
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA market size and forecast, by route of administration
7.5.9.2.Rest of LAMEA market size and forecast, by application
7.5.9.3.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.Abbott Laboratories
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.B. BRAUN MELSUNGEN AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.B. BRAUN operates through the following product:
8.2.6.Business performance
8.3.BAXTER INTERNATIONAL INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product Portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and development
8.4.Danone Nutricia
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.Fresenius SE & Co. KGaA
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.Hero Nutritionals Inc.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.Lonza Ltd.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.NESTLÉ S.A.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.PERRIGO COMPANY PLC
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Pfizer Inc.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
LIST OF TABLES
TABLE 01.CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 02.ORAL CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03.ENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04.PERENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05.CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 06.CANCER CLINICAL NUTRITION MARKET , BY REGION, 2018–2026 ($MILLION)
TABLE 07.NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET , BY REGION, 2018–2026 ($MILLION)
TABLE 08.GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET , BY REGION, 2018–2026 ($MILLION)
TABLE 09.METABOLIC DISORDERS CLINICAL NUTRITION MARKET , BY REGION, 2018–2026 ($MILLION)
TABLE 10.OTHERS CLINICAL NUTRITION MARKET , BY REGION, 2018–2026 ($MILLION)
TABLE 11.CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 12.PEDIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13.ADULT CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14.GERIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15.CLINICAL NUTRITION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 16.NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 17.NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 18.NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19.NORTH AMERICA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 20.U.S. CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 21.U.S. CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22.U.S. CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 23.CANADA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 24.CANADA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 25.CANADA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26.MEXICO CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 27.MEXICO CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 28.MEXICO CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 29.EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 30.EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 31.EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32.EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 33.GERMANY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 34.GERMANY CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35.GERMANY CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36.UK CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 37.UK CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 38.UK CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39.SPAIN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 40.SPAIN CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41.SPAIN CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 42.FRANCE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 43.FRANCE CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 44.FRANCE CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45.ITALY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 46.ITALY CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 47.ITALY CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 48.REST OF EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 49.REST OF EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 50.REST OF EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 51.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 52.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 53.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 55.JAPAN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 56.JAPAN CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 57.JAPAN CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58.CHINA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 59.CHINA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 60.CHINA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 61.INDIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 62.INDIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 63.INDIA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64.AUSTRALIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 65.AUSTRALIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 66.AUSTRALIA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 70.LAMEA CLINICAL NUTRITION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 71.LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 72.LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73.LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 74.BRAZIL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 75.BRAZIL CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76.BRAZIL CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 77.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 78.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 79.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 80.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 81.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 82.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 83.REST OF LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 84.REST OF LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 85.REST OF LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 86.ABBOTT: COMPANY SNAPSHOT
TABLE 87.ABBOTT: OPERATING SEGMENTS
TABLE 88.ABBOTT: PRODUCT PORTFOLIO
TABLE 89.B. BRAUN: COMPANY SNAPSHOT
TABLE 90.B. BRAUN: OPERATING SEGMENTS
TABLE 91.B. BRAUN: PRODUCT PORTFOLIO
TABLE 01.BAXTER: COMPANY SNAPSHOT
TABLE 02.BAXTER: BUSINESS SEGMENT
TABLE 03.NUTRICIA: COMPANY SNAPSHOT
TABLE 04.NUTRICIA: OPERATING SEGMENTS
TABLE 05.NUTRICIA: PRODUCT PORTFOLIO
TABLE 06.FRESENIUS: COMPANY SNAPSHOT
TABLE 07.FRESENIUS: OPERATING SEGMENTS
TABLE 08.FRESENIUS: PRODUCT PORTFOLIO
TABLE 09.HERO: COMPANY SNAPSHOT
TABLE 10.HERO: OPERATING SEGMENTS
TABLE 11.HERO: PRODUCT PORTFOLIO
TABLE 12.LONZA: COMPANY SNAPSHOT
TABLE 13.LONZA: OPERATING SEGMENTS
TABLE 14.LONZA: PRODUCT PORTFOLIO
TABLE 15.NESTLÉ: COMPANY SNAPSHOT
TABLE 16.NESTLÉ: OPERATING SEGMENTS
TABLE 17.NESTLÉ: PRODUCT PORTFOLIO
TABLE 18.PERRIGO: COMPANY SNAPSHOT
TABLE 19.PERRIGO: OPERATING SEGMENTS
TABLE 20.PERRIGO: PRODUCT PORTFOLIO
TABLE 21.PFIZER: COMPANY SNAPSHOT
TABLE 22.PFIZER: OPERATING SEGMENTS
TABLE 23.PFIZER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.CLINICAL NUTRITION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.CLINICAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 04.COMPARATIVE SHARE ANALYSIS OF ORAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 05.COMPARATIVE SHARE ANALYSIS OF ENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06.COMPARATIVE SHARE ANALYSIS OF PERENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07.COMPARATIVE SHARE ANALYSIS OF CANCER CLINICAL NUTRITION MARKET , BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF OTHERS CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF PEDIATRIC CLINICAL NUTRITION MARKET , BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ADULT CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GERIATRIC CLINICAL NUTRITION MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 16.ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 17.ABBOTT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 18.NET SALES, 2016–2018 ($MILLION)
FIGURE 19.B. BRAUN: NET SALES BY DIVISION, 2018 (%)
FIGURE 20.B. BRAUN: NET SALES BY REGION, 2018 (%)
FIGURE 01.NET SALES, 2016–2018 ($MILLION)
FIGURE 02.BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 03.BAXTER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 04.FRESENIUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 05.FRESENIUS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 06.FRESENIUS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 07.NET SALES, 2016–2018 ($MILLION)
FIGURE 08.LONZA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 09.LONZA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 10.NET SALES, 2016–2018 ($MILLION)
FIGURE 11.NESTLÉ: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 12.NESTLÉ: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 13.PERRIGO: NET SALES, 2016–2018 ($MILLION)
FIGURE 14.PERRIGO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 15.PERRIGO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 16.PFIZER NET SALES, 2016–2018 ($MILLION)
FIGURE 17.PFIZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 18.PFIZER: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
$5769
$8995
Add to Cart
Add to Cart
Add to Cart
Add to Cart